Genetics of Osteoporotic Fractures in Chinese
Genetics of Osteoporotic Fractures in Chinese
批准号:
8117113
负责人:
HONG-WEN DENG
金额:
$6.33万
依托单位国家:
美国
项目类别:
财政年份:
2009
资助国家:
美国
项目状态:
已结题
起止时间:
2009-09-01 至 2013-06-30
关键词:
AddressAgeAgingAreaBiomedical ResearchBone DensityCYP19A1 geneCandidate Disease GeneCaucasiansCaucasoid RaceChinaChinese PeopleCitiesCollaborationsComplementComplexConnecticutDevelopmentDiseaseFemaleFoundationsFundingGene Expression ProfileGene Expression ProfilingGene ProteinsGenesGeneticGenomeGenomicsGenotypeGoalsGovernmentGrantGrowth and Development functionHealthHigh Performance ComputingHip FracturesHip region structureHumanIncidenceIndividualInstitutesInstitutionInternationalInterventionKansasMedical ResearchMissouriMolecular GeneticsMorbidity - disease rateNatureNuclear FamilyOsteoclastsOsteoporosisOsteoporosis preventionOutcomePathogenesisPeer ReviewPersonsPhenotypePlayPopulationPredispositionPreventive InterventionProteomeProteomicsProvincePublic HealthPublicationsPublishingQuantitative Trait LociRecruitment ActivityResearchResearch PersonnelResourcesRiskRoleSNP genotypingSamplingSampling StudiesScanningScienceScientistSocietiesSolidSpecificityTNFRSF5 geneTestingTrainingUnited States National Institutes of HealthUniversitiesVariantWorkbasebone masscareercareer developmentcase controlexperiencegenetic pedigreegenetic risk factorglobal healthhip boneimprovedinsightjournal articlemonocytemortalitynovelosteoclastogenesisosteoporosis with pathological fracturepandemic diseaseparent grantparent projectperipheral bloodpublic health relevance
中文摘要
点击翻译按钮获取中文摘要
英文摘要
DESCRIPTION (provided by applicant): We request funding to support/strengthen an ongoing collaboration in basic biomedical research in the area of genetics of osteoporosis between the US-based and NIH-supported PI at University of Missouri-Kansas City (UMKC) and young scientists in Xi'an Jiaotong University (XJTU), China. The collaboration, spanning over the past 4 years and supported mainly by funding from China, has resulted in >20 publications in the field of osteoporosis, seeded promising research careers for several young scientists in China, and established platforms for genotyping, phenotyping, gene expression profiling and high performance computing for genetic studies of osteoporosis and other human complex diseases. Funding of this application will support continuation of this productive working relationship, which is essential to the development of basic medical research of osteoporosis in China, and accelerate career development of the young Chinese collaborators. If this application is funded, a match-up fund will be granted from the collaborating institution, XJTU, to serve as additional support for the proposed collaborative project in this proposal (Appendix z). Osteoporosis is a major public health problem, mainly characterized by low bone mineral density (BMD) and high susceptibility to osteoporotic fractures (OF). With the aging of the world population, the mortality and morbidity associated with OF places an increasingly heavy burden on modern societies in the west as well the east. So far, extensive efforts have been made to identify genes associated with BMD, with few studies directly examining OF as the study phenotype. However, OF is the devastating outcome of osteoporosis and studies showed that genes significant for BMD may not all be relevant to OF. Therefore, disclosing the genetic factors influencing BMD, which are also important to OF, should be of greater significance for understanding the pathogenesis of osteoporosis. Through various genetic and genomic approaches, we identified 2 prominent candidate genes (RANK and CYP19) significant for hip BMD in Caucasians. However, their significance to Chinese in terms of BMD and/or OF is unknown. In this study, our HYPOTHESIS is that genes significant for hip BMD in Caucasians are also associated with hip BMD and hip osteoporotic fractures (HF) in Chinese. The GOAL is to identify the genes for hip BMD and HF in Chinese by testing in Chinese the significance of the genes associated with hip BMD in Caucasians. Our Specific Aims are 1) To test association with hip BMD and HF in Chinese population of two genes, RANK and CYP19, which were associated with hip BMD in Caucasians; 2) To select another six osteoporosis candidate genes to be identified from our parent projects and test their association with hip BMD and OF in the Chinese population. This project will contribute to better understanding the genetic basis of osteoporosis in Chinese. The genes identified significant for hip BMD and HF in Chinese may serve as markers/targets for genotype-based prevention and intervention to reduce the incidence of HF. As an international support for the PI's collaboration with XJTU, this project will provide a unique opportunity to enhance the research experience and capability of the collaborating young scientists in China, to accelerate their transition into independent investigators, and to help advance the overall level of basic scientific research of osteoporosis in China. Together with the ongoing studies in Caucasians, this project will provide novel insights into the ethnic specificity and/or generality of the genetic basis of osteoporosis for the two major ethnic populations in the world, thus contribute to addressing the global problem of osteoporosis. PERFORMANCE SITE(S) (organization, city, state) University of Missouri- Kansas City (UMKC), Kansas City, Missouri, USA Xi'an Jiaotong University (XJTU), Xi'an, Shaanxi Province, P.R. China Yale University, New Heaven, CT, USA University of Connecticut, Farmington, CT, USA PHS 398 (Rev. 04/06) PUBLIC HEALTH RELEVANCE: Osteoporosis is a disease mainly characterized by low bone mineral density (BMD), predisposing a person to an increased risk of osteoporotic fracture (OF). OF at hip is the most devastating outcome of osteoporosis. Though extensive efforts have been made to identify genes underlying osteoporosis, most of the genetic studies were focused on its surrogate phenotype BMD, and few studies directly study OF per se as the phenotype for osteoporosis. The goal of this project is to identify the genes not only for BMD but also for OF in Chinese, by testing in a large Chinese sample the osteoporosis candidate genes identified in Caucasians. This project will contribute to better understanding the genetic basis of osteoporosis in Chinese. The results will provide novel insights into the ethnic specificity and/or generality of the genetic determination of osteoporosis for the two major ethnic populations, i.e., Caucasians and Chinese, thus contribute to addressing this global health problem. The genes identified may serve as targets for genotype-specific interventions to reduce the incidence of OF, and eventually improve the control of osteoporosis pandemic and enhance people's health in China. PHS 398 (Rev. 04/06)
期刊论文(1)
专著(0)
科研奖励(0)
会议论文
DOI:
10.1016/j.gene.2016.01.036
发表时间:
2016-05-01
期刊:
Gene
影响因子:
3.5
作者:
[Liu YZ, Maney P, Puri J, Zhou Y, Baddoo M, Strong M, Wang YP, Flemington E, Deng HW]
通讯作者:
Deng HW
Project 1: Genome Wide Sequencing for Osteoporosis Risk Genes in Males
-
批准号:10180818
-
项目类别:
-
资助金额:$72.49万
-
财政年份:2017
-
负责人:HONG-WEN DENG
-
依托单位:
Decoding Methylation Mediated Epigenomic Contributions to Male Osteoporosis
-
批准号:9905489
-
项目类别:
-
资助金额:$62.0万
-
财政年份:2017
-
负责人:HONG-WEN DENG
-
依托单位:
Trans-omics integration of multi-omics studies for male osteoporosis
-
批准号:10216820
-
项目类别:
-
资助金额:$181.93万
-
财政年份:2017
-
负责人:HONG-WEN DENG
-
依托单位:
Trans-omics integration of multi-omics studies for male osteoporosis
-
批准号:10180814
-
项目类别:
-
资助金额:$170.58万
-
财政年份:2017
-
负责人:HONG-WEN DENG
-
依托单位:
Administrative Core
-
批准号:10180815
-
项目类别:
-
资助金额:$20.55万
-
财政年份:2017
-
负责人:HONG-WEN DENG
-
依托单位:
Trans-omics integration of multi-omics studies for male osteoporosis
-
批准号:9916677
-
项目类别:
-
资助金额:$154.07万
-
财政年份:2017
-
负责人:HONG-WEN DENG
-
依托单位:
Epigenomewide DNA Methylation Study for Osteoporosis Risk
-
批准号:9138957
-
项目类别:
-
资助金额:$60.55万
-
财政年份:2012
-
负责人:HONG-WEN DENG
-
依托单位:
Epigenomewide DNA Methylation Study for Osteoporosis Risk
-
批准号:8368888
-
项目类别:
-
资助金额:$65.12万
-
财政年份:2012
-
负责人:HONG-WEN DENG
-
依托单位:
Epigenomewide DNA Methylation Study for Osteoporosis Risk
-
批准号:8536726
-
项目类别:
-
资助金额:$59.4万
-
财政年份:2012
-
负责人:HONG-WEN DENG
-
依托单位:
Genome Wide Scans for Female Osteoporosis
-
批准号:8326789
-
项目类别:
-
资助金额:$5.97万
-
财政年份:2011
-
负责人:HONG-WEN DENG
-
依托单位:
OD Co-funding (-03 Budget Period)
-
批准号:8326792
-
项目类别:
-
资助金额:$97.5万
-
财政年份:2011
-
负责人:HONG-WEN DENG
-
依托单位:
Identification of Proteins Important for Male Osteoporosis
-
批准号:8143422
-
项目类别:
-
资助金额:$62.0万
-
财政年份:2009
-
负责人:HONG-WEN DENG
-
依托单位:
Genome-wide association study of periodontitis
-
批准号:8311274
-
项目类别:
-
资助金额:$1.73万
-
财政年份:2009
-
负责人:HONG-WEN DENG
-
依托单位:
Proteome-wide Expression Study of Osteogenic Cells
-
批准号:7936857
-
项目类别:
-
资助金额:$1.94万
-
财政年份:2009
-
负责人:HONG-WEN DENG
-
依托单位:
Identification of Proteins Important for Male Osteoporosis
-
批准号:8535075
-
项目类别:
-
资助金额:$53.71万
-
财政年份:2009
-
负责人:HONG-WEN DENG
-
依托单位:
Identification of Proteins Important for Male Osteoporosis
-
批准号:7742808
-
项目类别:
-
资助金额:$65.93万
-
财政年份:2009
-
负责人:HONG-WEN DENG
-
依托单位:
Identification of Proteins Important for Male Osteoporosis
-
批准号:8259560
-
项目类别:
-
资助金额:$0.0万
-
财政年份:2009
-
负责人:HONG-WEN DENG
-
依托单位:
OD Co-funding (-03 Budget Period)
-
批准号:7936858
-
项目类别:
-
资助金额:$97.5万
-
财政年份:2009
-
负责人:HONG-WEN DENG
-
依托单位:
Genetics of Osteoporotic Fractures in Chinese
-
批准号:8239109
-
项目类别:
-
资助金额:$2.54万
-
财政年份:2009
-
负责人:HONG-WEN DENG
-
依托单位:
Biostatistics and Bioinformatics Core
-
批准号:7936860
-
项目类别:
-
资助金额:$2.72万
-
财政年份:2009
-
负责人:HONG-WEN DENG
-
依托单位:
国内基金
海外基金
登录
查看更多内容
补阳还五汤通过AGE-RAGE通路调控脓毒症免疫失衡的机制与转化研究
-
批准号:JCZRLH202601523
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2026
-
负责人:
-
依托单位:
靶向递送一氧化碳调控AGE-RAGE级联反应促进糖尿病创面愈合研究
-
批准号:JCZRQN202500010
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2025
-
负责人:
-
依托单位:
对香豆酸抑制AGE-RAGE-Ang-1通路改善海马血管生成障碍发挥抗阿尔兹海默病作用
-
批准号:2025JJ70209
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2025
-
负责人:雷芬芳
-
依托单位:
AGE-RAGE通路调控慢性胰腺炎纤维化进程的作用及分子机制
-
批准号:--
-
项目类别:面上项目
-
资助金额:--
-
批准年份:2024
-
负责人:万荣
-
依托单位:
甜茶抑制AGE-RAGE通路增强突触可塑性改善小鼠抑郁样行为
-
批准号:2023JJ50274
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2023
-
负责人:贺志明
-
依托单位:
蒙药额尔敦-乌日勒基础方调控AGE-RAGE信号通路改善术后认知功能障碍研究
-
批准号:--
-
项目类别:地区科学基金项目
-
资助金额:33万元
-
批准年份:2022
-
负责人:都义日
-
依托单位:
补肾健脾祛瘀方调控AGE/RAGE信号通路在再生障碍性贫血骨髓间充质干细胞功能受损的作用与机制研究
-
批准号:--
-
项目类别:面上项目
-
资助金额:52万元
-
批准年份:2022
-
负责人:叶宝东
-
依托单位:
LncRNA GAS5在2型糖尿病动脉粥样硬化中对AGE-RAGE 信号通路上相关基因的调控作用及机制研究
-
批准号:
-
项目类别:省市级项目
-
资助金额:10.0万元
-
批准年份:2022
-
负责人:于海兵
-
依托单位:
围绕GLP1-Arginine-AGE/RAGE轴构建探针组学方法探索大柴胡汤异病同治的效应机制
-
批准号:81973577
-
项目类别:面上项目
-
资助金额:55.0万元
-
批准年份:2019
-
负责人:辛贵忠
-
依托单位:
AGE/RAGE通路microRNA编码基因多态性与2型糖尿病并发冠心病的关联研究
-
批准号:81602908
-
项目类别:青年科学基金项目
-
资助金额:18.0万元
-
批准年份:2016
-
负责人:刘括
-
依托单位: